Table 2. CAR in respiratory patients in different treatment groups
NRT (n=61)
Bupropion (n=79)
Varenicline (n=117)
At the end on treatment
50.9%
56.2%
75.6%
6 months
55.3%
54%
66.7%
12 months
46.7%
37.7%
47.8%